Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

8.44
Delayed Data
As of Jun 24
 0.00 / 0.00%
Today’s Change
6.96
Today|||52-Week Range
25.25
-51.30%
Year-to-Date

Today’s Trading

Previous close8.44
Today’s openn.a.
Day’s range8.44 - 9.10
Volume230,967
Average volume (3 months)1,723,250
Market cap$1.1B
Dividend yield--
Data as of 06/24/2016

Growth & Valuation

Earnings growth (last year)+55.36%
Earnings growth (this year)-310.38%
Earnings growth (next 5 years)--
Revenue growth (last year)+79.28%
P/E ratioNM
Price/Sales16.26
Price/Book25.63

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...0.000.00%
AXONAxovant Sciences Ltd0.000.00%
MCRBSeres Therapeutics I...0.000.00%
AVXSAveXis Inc0.000.00%
Data as of 06/24/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$135.1M
Annual profit (last year)-$32.2M
Net profit margin-23.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

Partner Offers

Search for Jobs